207 related articles for article (PubMed ID: 24119107)
1. Cytokine profiling in patients with VCP-associated disease.
Dec E; Rana P; Katheria V; Dec R; Khare M; Nalbandian A; Leu SY; Radom-Aizik S; Llewellyn K; BenMohamed L; Zaldivar F; Kimonis V
Clin Transl Sci; 2014 Feb; 7(1):29-32. PubMed ID: 24119107
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic variability in three families with valosin-containing protein mutation.
Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
[TBL] [Abstract][Full Text] [Related]
3. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
[TBL] [Abstract][Full Text] [Related]
4. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
[TBL] [Abstract][Full Text] [Related]
5. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
[TBL] [Abstract][Full Text] [Related]
6. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron involvement in multisystem proteinopathy: implications for ALS.
Benatar M; Wuu J; Fernandez C; Weihl CC; Katzen H; Steele J; Oskarsson B; Taylor JP
Neurology; 2013 May; 80(20):1874-80. PubMed ID: 23635965
[TBL] [Abstract][Full Text] [Related]
8. [Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia].
Hayashi Y
Rinsho Shinkeigaku; 2013; 53(11):947-50. PubMed ID: 24291843
[TBL] [Abstract][Full Text] [Related]
9. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
[TBL] [Abstract][Full Text] [Related]
10. A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation.
Shinjo SK; Oba-Shinjo SM; Lerario AM; Marie SKN
Clin Rheumatol; 2018 Apr; 37(4):1129-1136. PubMed ID: 29127544
[TBL] [Abstract][Full Text] [Related]
11. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
[TBL] [Abstract][Full Text] [Related]
12. Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family.
Kim EJ; Park YE; Kim DS; Ahn BY; Kim HS; Chang YH; Kim SJ; Kim HJ; Lee HW; Seeley WW; Kim S
Arch Neurol; 2011 Jun; 68(6):787-96. PubMed ID: 21320982
[TBL] [Abstract][Full Text] [Related]
13. [An advanced case of myopathy and dementia with a new mutation in the valosin-containing protein gene].
Kamiyama T; Sengoku R; Sasaki M; Hayashi Y; Nishino I; Mochio S; Iguchi Y
Rinsho Shinkeigaku; 2013; 53(6):465-9. PubMed ID: 23782825
[TBL] [Abstract][Full Text] [Related]
14. A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.
Fanganiello RD; Kimonis VE; Côrte CC; Nitrini R; Passos-Bueno MR
Braz J Med Biol Res; 2011 Apr; 44(4):374-80. PubMed ID: 21412659
[TBL] [Abstract][Full Text] [Related]
15. The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress.
Rodriguez-Ortiz CJ; Flores JC; Valenzuela JA; Rodriguez GJ; Zumkehr J; Tran DN; Kimonis VE; Kitazawa M
Am J Pathol; 2016 Jun; 186(6):1623-34. PubMed ID: 27106764
[TBL] [Abstract][Full Text] [Related]
16. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.
Bayraktar O; Oral O; Kocaturk NM; Akkoc Y; Eberhart K; Kosar A; Gozuacik D
PLoS One; 2016; 11(10):e0164864. PubMed ID: 27768726
[TBL] [Abstract][Full Text] [Related]
17. Novel valosin containing protein mutation in a Swiss family with hereditary inclusion body myopathy and dementia.
Wang H; Wu S
Neuromuscul Disord; 2015 Mar; 25(3):273. PubMed ID: 25497399
[No Abstract] [Full Text] [Related]
18. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.
Bartolome F; Wu HC; Burchell VS; Preza E; Wray S; Mahoney CJ; Fox NC; Calvo A; Canosa A; Moglia C; Mandrioli J; Chiò A; Orrell RW; Houlden H; Hardy J; Abramov AY; Plun-Favreau H
Neuron; 2013 Apr; 78(1):57-64. PubMed ID: 23498975
[TBL] [Abstract][Full Text] [Related]
20. Another VCP interactor: NF is enough.
Weihl CC
J Clin Invest; 2011 Dec; 121(12):4627-30. PubMed ID: 22105166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
